Table 1.
Clinical characteristics of BAM and WEM with type 2 diabetes
| Characteristic | BAM | WEM | Sample sizeBAM/WEM | p |
|---|---|---|---|---|
| Age (years)a | 54.0 (47.9, 60.2) | 59.0 (55.5, 62.5) | 18/15 | 0.51 |
| Weight (kg) | 90.9 (9.3) | 94.2 (11.6) | 18/15 | 0.38 |
| Height (cm) | 175.6 (7.6) | 176.8 (5.8) | 18/15 | 0.91 |
| BMI (kg/m2) | 29.5 (2.7) | 30.1 (2.7) | 18/15 | 0.55 |
| Waist circumference (cm) | 103.6 (8.4) | 107.5 (8.8) | 18/15 | 0.20 |
| BSA (m2) | 2.08 (0.14) | 2.13 (0.15) | 18/15 | 0.40 |
| VAT mass (kg) | 3.72 (1.07) | 5.68 (2.43) | 17/14 | 0.01* |
| SAT mass (kg) | 11.8 (3.9) | 11.8 (2.6) | 16/14 | 0.98 |
| Skeletal muscle mass (kg)b | 20.7 (2.5) | 18.5 (3.0) | 17/14 | 0.03* |
| Duration of diabetes (years)a | 3.0 (2.5, 3.6) | 3.0 (2.0, 4.0) | 18/15 | 0.74 |
| HbA1c (mmol/mol) | 50.4 (7.5) | 48.6 (7.8) | 18/15 | 0.50 |
| Systolic BP (mmHg) | 138.4 (13.6) | 131.8 (13.9) | 18/15 | 0.18 |
| Diastolic BP (mmHg) | 86.9 (5.1) | 82.9 (10.1) | 18/15 | 0.19 |
| Total cholesterol (mmol/l) | 4.17 (0.68) | 4.30 (0.72) | 18/15 | 0.61 |
| LDL-cholesterol (mmol/l) | 2.37 (0.53) | 2.29 (0.70) | 18/15 | 0.71 |
| HDL-cholesterol (mmol/l) | 1.19 (0.38) | 1.24 (0.24) | 18/15 | 0.66 |
| Triacylglycerol (mmol/l)c | 1.20 (0.95, 1.52) | 1.58 (1.26, 1.97) | 18/15 | 0.09 |
| Treated with metformin (%) | 78d | 53e | 18/15 | 0.16 |
Data expressed as mean (SD) for normally distributed data unless otherwise shown
aMedian (interquartile range) for skewed distributed data
bSkeletal muscle mass was measured from neck to knee excluding arms
cGeometric mean (95% CI) for log-transformed data or as percentage of individuals where required
dn = 14
en = 8
*p < 0.05
p values were generated using an independent sample Student’s t test for normally distributed data and Mann–Whitney U test for skewed data to compare BAM and WEM